Focus:

Cancer Center Featured Story 2

Add to Favorites Subscribe Share
Newswise: Dozens of potential anti-cancer drugs netted in massive screening study
  • Embargo expired:
    20-Jan-2020 11:00 AM EST

Dozens of potential anti-cancer drugs netted in massive screening study

Dana-Farber Cancer Institute

A variety of existing drugs for treating conditions such as diabetes, inflammation, alcohol abuse, and arthritis in dogs can also kill cancer cells in the lab, according to a study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Channels: All Journal News, Grant Funded News, Cancer, Clinical Trials, Pharmaceuticals, National Institutes of Health (NIH), Nature (journal),

Released:
19-Jan-2020 11:05 AM EST
Newswise: Why aren’t advanced bladder cancers being treated?

Why aren’t advanced bladder cancers being treated?

UC Davis Comprehensive Cancer Center

Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don’t get it. The result, argues a team led by UC Davis Health urologists, is that the disease for many is still as deadly as it was 30 years ago.

Channels: Cancer, Healthcare, Surgery, All Journal News,

Released:
20-Jan-2020 9:00 AM EST
Research Results
Newswise: Cancer study may accidentally help researchers create usable blood stem cells

Cancer study may accidentally help researchers create usable blood stem cells

University of Colorado Cancer Center

University of Colorado Cancer Center study shows healthy form of the leukemia-causing gene MLL may push pluripotent stem cells (which have proven difficult to use in human patients) to become durable hematopoietic stem cells (which are usable in patients, but have until now been impossible to make).

Channels: All Journal News, Blood, Cancer, Cell Biology, Stem Cells, Grant Funded News,

Released:
16-Jan-2020 2:00 PM EST
Research Results
and-logo.jpg
  • Embargo expired:
    15-Jan-2020 1:00 PM EST
Released:
14-Jan-2020 11:55 AM EST
Research Results
Newswise: Memorial Sloan Kettering Appoints Roxanne Taylor as Chief Marketing and Communications Officer

Memorial Sloan Kettering Appoints Roxanne Taylor as Chief Marketing and Communications Officer

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center has appointed Roxanne Taylor as Chief Marketing and Communications Officer, effective February 3. In this role, Ms. Taylor will be responsible for shaping and enhancing the MSK brand and will be accountable for building the long-term equity of the brand with all stakeholders.

Channels: Business Ethics, Cancer, Healthcare, In the Workplace, Marketing,

Released:
14-Jan-2020 11:00 AM EST
Research Results
Newswise: Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

Ludwig Cancer Research

Ludwig Cancer Research is pleased to announce the appointment of Douglas Hanahan as a Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research.

Channels: Cancer, Immunology, In the Workplace,

Released:
14-Jan-2020 3:00 AM EST
Announcement
Newswise: Dana-Farber Cancer Institute to Establish Riney Family Multiple Myeloma Initiative

Dana-Farber Cancer Institute to Establish Riney Family Multiple Myeloma Initiative

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.

Channels: Cancer, Family and Parenting, Healthcare, Grant Funded News,

Released:
13-Jan-2020 9:00 AM EST
Announcement
Newswise: Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital

Sanft named Chief Patient Experience Officer at Smilow Cancer Hospital

Yale Cancer Center

Tara Sanft, M.D., associate professor of Medicine (Medical Oncology) and Director of the Smilow Cancer Hospital (SCH) Survivorship Clinic, has been appointed the inaugural Chief Patient Experience Officer at Yale Cancer Center (YCC) and SCH at Yale New Haven Hospital.

Channels: Cancer, Healthcare, In the Workplace,

Released:
10-Jan-2020 3:35 PM EST
Announcement
Newswise: Mougalian appointed Deputy Chief Ambulatory Officer at Smilow Cancer Hospital

Mougalian appointed Deputy Chief Ambulatory Officer at Smilow Cancer Hospital

Yale Cancer Center

Sarah Mougalian, M.D., assistant professor of Medicine (Medical Oncology) has been named the inaugural Deputy Chief Ambulatory Officer at Smilow Cancer Hospital (SCH) at Yale New Haven Hospital.

Channels: Cancer, Healthcare, In the Workplace,

Released:
10-Jan-2020 3:30 PM EST
Announcement
logoMOFFITT_2c_RGB.jpg

Moffitt Researchers Identify Molecular Characteristics of Leptomeningeal Melanoma Metastases

Moffitt Cancer Center

Very little information is known about the molecular development of leptomeningeal melanoma metastases (LMM), making it difficult to develop effective therapies. Researchers in Moffitt Cancer Center’s Donald A. Adam Melanoma and Skin Cancer Center of Excellence and the Department of Neuro-Oncology sought to change this by performing an extensive analysis of the molecular characteristics of the cerebrospinal fluid of patients with LMM. Their findings were published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Channels: Cancer, Dermatology, Healthcare, National Institutes of Health (NIH), All Journal News,

Released:
10-Jan-2020 10:30 AM EST
Announcement


6.80037